Dhingra Ankur - Insider Transactions
Insider Type
individual
Companies
2
Average
705,008
Total Txns
5
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2023 | 2 | 0 | 2 | 44,254.00 | 0.00 | 44,254.00 |
| 2024 | 1 | 0 | 1 | 375,000.00 | 0.00 | 375,000.00 |
| 2025 | 2 | 0 | 2 | 990,762.00 | 0.00 | 990,762.00 |
| Total: | 5 | 0 | 5 | 1,410,016.00 | 0.00 | 1,410,016.00 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Illumina, Inc. Common Stock US4523271090 |
81.21 USD |
6,100 Bought |
495,381 USD |
12/05/2025 | 12/05/2025 |
| Illumina, Inc. Common Stock US4523271090 |
81.21 USD |
6,100 Bought |
495,381 USD |
12/05/2025 | 12/05/2025 |
| Summit Therapeutics Inc. Common Stock US86627T1088 |
3.75 USD |
100,000 Bought |
375,000 USD |
26/03/2024 | 26/03/2024 |
| Summit Therapeutics Inc. Common Stock US86627T1088 |
2.15 USD |
700 Bought |
1,505 USD |
13/12/2023 | 13/12/2023 |
| Summit Therapeutics Inc. Common Stock US86627T1088 |
2.17 USD |
19,700 Bought |
42,749 USD |
13/12/2023 | 13/12/2023 |